Lupin has received approval for its Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg from the United States Food and Drug
Administration (FDA) to market a generic version of SpecGx LLC's Anafranil Capsules, 25 mg, 50 mg, and 75 mg.
Lupin's Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg is the generic version of SpecGx LLC's Anafranil Capsules, 25 mg, 50 mg, and 75 mg. It is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Anafranil Capsules, 25 mg, 50 mg, and 75 mg had annual sales of approximately USD 109.6 millionin the US (IQVIA MAT September 2018).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
